Nimodipine in the treatment of acute MCA ischemic stroke. Cerebrovasc Dis - Hennerici, Kramer, et al. - 1994Hennerici M, Kramer G, North PM, Schmitz H, Tettenborn D. Nimo- dipine in the treatment of acute MCA ischemic stroke. Cerebrovasc Dis. 1994;4:189 -193....
Stroke remains the third most important cause of mortality in industrialized countries; this has prompted research for improvements in both diagnostic and
membranous pattern in the microglial cells. In a human stroke patient, an increase of P16 in the perimeter of the MCA infarct area was observed. These suggest a role of SASP in tMCAo mouse model and in human brain tissue. SASP potentially has a physiological role in acute ischemic stroke a...
Knowledge of thrombus behavior and visualization on MRI in acute ischemic stroke is less than optimal. However, MRI sequences could be enhanced based on the typical T1 and T2 relaxation times of the target tissues, which mainly determine their signal intensities on imaging. We studied the relaxati...
The clinical manifestations and imaging data of the patient were consistent with acute ischemic stroke [13]; 2.Age ≥ 18 years; 3.Complete clinical data and signed the informed consent for intravenous thrombolytic therapy and enrollment;4. The Ethics Committee of our hospital has approved ...
However, this phenomenon is unexpected when an acutely occluded artery is recanalized by intravenous tissue plasminogen activator (IV-TPA) for acute ischemic stroke (AIS). We describe a series of 8 patients with CHS seen on multimodal hemodynamic and functional evaluations after ...
EMS, Emergency Management of StrokeICH, intracranial hemorrhageMCA, middle cerebral arteryMRI, magnetic resonance imagingIntravenous recombinant tissue-type plasminogen activator is approved by the US Food and Drug Administration for treating acute ischemic stroke within 3 hours of onset of symptoms. ...
Acute ischemic stroke LVO: Large vessel occlusion ICA: Internal carotid artery MCA: Middle cerebral artery MT: Mechanical thrombectomy HT: Hemorrhagic transformation CTP: Computed tomography perfusion MRI: Magnetic resonance imaging FLAIR: Fluid-attenuated inversion recovery ...
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. specific and nonneurotoxic thrombolytic agent, administered within 3 to 9 hours of ischemic stroke onset in patients with perfusion/diffusion ...
Deep learning-based detection and segmentation of diffusion abnormalities in acute ischemic stroke Chin-Fu Liu, Johnny Hsu, Xin Xu, Sandhya Ramachandran, Victor Wang, Michael I. Miller, Argye E. Hillis, Andreia V. Faria & The STIR and VISTA Imaging investigators Communications Medicine...